373 related articles for article (PubMed ID: 18688174)
1. Inflammatory markers in the tears of patients with ocular surface disease.
Acera A; Rocha G; Vecino E; Lema I; Durán JA
Ophthalmic Res; 2008 Oct; 40(6):315-21. PubMed ID: 18688174
[TBL] [Abstract][Full Text] [Related]
2. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
3. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
4. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis.
Acera A; Vecino E; Duran JA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8285-91. PubMed ID: 24255042
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory molecules in the tears of patients with keratoconus.
Lema I; Durán JA
Ophthalmology; 2005 Apr; 112(4):654-9. PubMed ID: 15808258
[TBL] [Abstract][Full Text] [Related]
7. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
[TBL] [Abstract][Full Text] [Related]
8. Analysis of inflammatory cytokines in the tears of dry eye patients.
Massingale ML; Li X; Vallabhajosyula M; Chen D; Wei Y; Asbell PA
Cornea; 2009 Oct; 28(9):1023-7. PubMed ID: 19724208
[TBL] [Abstract][Full Text] [Related]
9. Elevated tear interleukin-6 and interleukin-8 levels in patients with conjunctivochalasis.
Erdogan-Poyraz C; Mocan MC; Bozkurt B; Gariboglu S; Irkec M; Orhan M
Cornea; 2009 Feb; 28(2):189-93. PubMed ID: 19158563
[TBL] [Abstract][Full Text] [Related]
10. The role of oxidative stress and inflammation in conjunctivochalasis.
Ward SK; Wakamatsu TH; Dogru M; Ibrahim OM; Kaido M; Ogawa Y; Matsumoto Y; Igarashi A; Ishida R; Shimazaki J; Schnider C; Negishi K; Katakami C; Tsubota K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1994-2002. PubMed ID: 20019361
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
12. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects.
Lema I; Durán JA; Ruiz C; Díez-Feijoo E; Acera A; Merayo J
Cornea; 2008 Aug; 27(7):758-63. PubMed ID: 18650659
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
16. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments.
Sack R; Conradi L; Beaton A; Sathe S; McNamara N; Leonardi A
Exp Eye Res; 2007 Oct; 85(4):528-38. PubMed ID: 17719576
[TBL] [Abstract][Full Text] [Related]
17. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays.
Boehm N; Riechardt AI; Wiegand M; Pfeiffer N; Grus FH
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7725-30. PubMed ID: 21775656
[TBL] [Abstract][Full Text] [Related]
20. Subclinical keratoconus and inflammatory molecules from tears.
Lema I; Sobrino T; Durán JA; Brea D; Díez-Feijoo E
Br J Ophthalmol; 2009 Jun; 93(6):820-4. PubMed ID: 19304583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
